Neuroendocrine tumor G1 (net G1)/carcinoid

Clinical trials for Neuroendocrine tumor G1 (net G1)/carcinoid explained in plain language.

Never miss a new study

Get alerted when new Neuroendocrine tumor G1 (net G1)/carcinoid trials appear

Sign up with your email to follow new studies for Neuroendocrine tumor G1 (net G1)/carcinoid, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Terminated 1

Promising cancer drug trial halted after just one patient

Disease control Stopped early

This study aimed to see if giving Lutathera (a radioactive drug) after surgery to remove liver metastases from neuroendocrine tumors could help keep the cancer from coming back. It planned to compare Lutathera plus best supportive care against best supportive care alone in about …

Matched conditions: NEUROENDOCRINE TUMOR G1 (NET G1)/CARCINOID

Phase 2 • Sponsor: Imperial College London • Aim: Disease control

Last updated Jun 27, 2026 08:12 UTC

Neuroendocrine tumor G1 (net G1)/carcinoid

Get alerted when new Neuroendocrine tumor G1 (net G1)/carcinoid trials appear

Promising cancer drug trial halted after just one patient